The efficacy and safety of the novel long-acting β2 agonist vilanterol in patients with COPD: A randomized placebo-controlled trial
- Nicola A. Hanania*
- , Gregory Feldman
- , Wolfgang Zachgo
- , Jae Jeong Shim
- , Courtney Crim
- , Lisa Sanford
- , Sally Lettis
- , Frank Barnhart
- , Brett Haumann
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
98
Link opens in a new tab
Citations
(Scopus)